Chief Executive Officer

Head of Research and Development

Day One Biopharmaceuticals management to meet with Piper Sandler

Transcript : Day One Biopharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08

Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman

Day One Biopharmaceuticals initiated with bullish view at Piper Sandler, here's why

Document Control and Training Specialist

Day One Biopharmaceuticals is focused on advancing innovative medicines for childhood and adult diseases. The Document Control and Training Specialist will oversee the management of controlled documents in compliance with GMP regulations and support the quality system, while also providing training to personnel and managing document control processes.

Sign up with Google

Sign in with Google